NCT02834013 2026-04-13Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting818 enrolled
NCT03860272 2026-03-30Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerAgenus Inc.Phase 1 Active not recruiting499 enrolled
NCT05826600 2026-01-06A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed SurgicallyiOmx Therapeutics AGPhase 1/2 Active not recruiting188 enrolled
NCT03331250 2025-12-23Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)Massachusetts General HospitalPhase 2 Active not recruiting13 enrolled 9 charts